Previous Close | 63.40 |
Open | 63.73 |
Bid | 63.81 x 28400 |
Ask | 63.83 x 2100 |
Day's Range | 63.69 - 64.55 |
52 Week Range | 43.90 - 67.99 |
Volume | |
Avg. Volume | 4,107,836 |
Market Cap | 62.62B |
Beta (5Y Monthly) | 1.19 |
PE Ratio (TTM) | 424.93 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.00 (3.31%) |
Ex-Dividend Date | May 02, 2022 |
1y Target Est | N/A |
Regeneron (REGN) announces positive data on a phase III study on cholesterol treatment Evkeeza.
(Bloomberg) -- Can Latin America seize the opportunities in front of it stemming from supply chain disruptions, cheap labor and a growing technology industry in order to revert a decade of tepid growth? Most Read from BloombergOne of the World’s Frothiest Housing Markets Turned Into a Seller’s Headache OvernightChina in Talks With Russia to Buy Oil for Strategic ReservesApple Shows AR/VR Headset to Board in Sign of Progress on Key Project Elon Musk Gets Defensive Over Twitter Meme as Harassment
Pfizer (PFE) is set to buy migraine drugmaker, Biohaven Pharmaceuticals for $11.6 billion. Bayer (BAYRY) beats Q1 earnings and sales expectations.